References
1 Yu B, Ouyang B, Ge S, et al. Incidence of postoperative residual neuromuscular blockade after general anesthesia: a prospective, multicenter, anesthetist-blind, observational study. Curr Med Res Opin 2016; 32 : 1-9
2 Hunter JM. Reversal of residual neuromuscular block: complications associated with perioperative management of muscle relaxation. Br J Anaesth 2017; 119 : i53-i62
3 Kirmeier E, Eriksson LI, Lewald H, et al. Post-anaesthesia pulmonary complications after use of muscle relaxants (POPULAR): a multicentre, prospective observational study. The Lancet Respiratory Medicine2019; 7 : 129-40
4 de Boer HD, Carlos RV, Brull SJ. Is lower-dose sugammadex a cost-saving strategy for reversal of deep neuromuscular block? Facts and fiction. BMC Anesthesiol 2018; 18 : 159
5 Savic L, Savic S, Hopkins PM. Sugammadex: the sting in the tail?Br J Anaesth 2018; 121 : 694-7
6 Carron M, Zarantonello F, Tellaroli P, Ori C. Efficacy and safety of sugammadex compared to neostigmine for reversal of neuromuscular blockade: a meta-analysis of randomized controlled trials. J Clin Anesth 2016; 35 : 1-12
7 Hristovska AM, Duch P, Allingstrup M, Afshari A. The comparative efficacy and safety of sugammadex and neostigmine in reversing neuromuscular blockade in adults. A Cochrane systematic review with meta-analysis and trial sequential analysis. Anaesthesia 2018;73 : 631-41
8 Plaud B, Baillard C, Bourgain JL, et al. Guidelines on muscle relaxants and reversal in anaesthesia. Anaesth Crit Care Pain Med2020; 39 : 125-42
9 M L. VigiBase, the WHO Global ICSR Database System: Basic Facts.Drug Information Journal 2008; 42 : 409-19
10 Lagerlund O, Strese S, Fladvad M, Lindquist M. WHODrug: A Global, Validated and Updated Dictionary for Medicinal Information. Ther Innov Regul Sci 2020; 54 : 1116-22
11 Hou Y, Ye X, Wu G, Cheng G, Du X, He J. A comparison of disproportionality analysis methods in national adverse drug reaction databases of China. Expert Opin Drug Saf 2014; 13 : 853-7
12 Tada K, Maruo K, Isogawa N, Yamaguchi Y, Gosho M. Borrowing external information to improve Bayesian confidence propagation neural network.Eur J Clin Pharmacol 2020; 76 : 1311-9
13 Bai X, Lin X, Zheng K, et al. Mapping endocrine toxicity spectrum of immune checkpoint inhibitors: a disproportionality analysis using the WHO adverse drug reaction database, VigiBase. Endocrine 2020;69 : 670-81
14 Noren GN, Hopstadius J, Bate A. Shrinkage observed-to-expected ratios for robust and transparent large-scale pattern discovery. Stat Methods Med Res 2013; 22 : 57-69
15 Jabaley CS, Wolf FA, Lynde GC, O’Reilly-Shah VN. Crowdsourcing sugammadex adverse event rates using an in-app survey: feasibility assessment from an observational study. Ther Adv Drug Saf 2018;9 : 331-42
16 Nemes R, Fulesdi B, Pongracz A, et al. Impact of reversal strategies on the incidence of postoperative residual paralysis after rocuronium relaxation without neuromuscular monitoring: A partially randomised placebo controlled trial. Eur J Anaesthesiol 2017; 34 : 609-16
17 Errando CL, Garutti I, Mazzinari G, Diaz-Cambronero O, Bebawy JF, Grupo Espanol De Estudio Del Bloqueo N. Residual neuromuscular blockade in the postanesthesia care unit: observational cross-sectional study of a multicenter cohort. Minerva Anestesiol 2016; 82 : 1267-77
18 Bhavani SS. Severe bradycardia and asystole after sugammadex.Br J Anaesth 2018; 121 : 95-6
19 Yoshida T, Sumi C, Uba T, Miyata H, Umegaki T, Kamibayashi T. A rare case of atropine-resistant bradycardia following sugammadex administration. JA Clin Rep 2020; 6 : 18
20 King A, Naguib A, Tobias JD. Bradycardia in a Pediatric Heart Transplant Recipient: Is It the Sugammadex? J Pediatr Pharmacol Ther 2017; 22 : 378-81
21 Fierro C, Medoro A, Mignogna D, et al. Severe Hypotension, Bradycardia and Asystole after Sugammadex Administration in an Elderly Patient. Medicina (Kaunas) 2021; 57
22 Hunter JM, Naguib M. Sugammadex-induced bradycardia and asystole: how great is the risk? Br J Anaesth 2018; 121 : 8-12
23 Gaver RS, Brenn BR, Gartley A, Donahue BS. Retrospective Analysis of the Safety and Efficacy of Sugammadex Versus Neostigmine for the Reversal of Neuromuscular Blockade in Children. Anesthesia & Analgesia 2019; 129 : 1124-9
24 Honing G, Martini CH, Bom A, et al. Safety of sugammadex for reversal of neuromuscular block. Expert Opin Drug Saf 2019; 18 : 883-91